What does Pharmacie Franco Belge do?

Pharmacie Franco Belge is a logistics company in Brussel. Private Limited, started on 1 January 1968, 1 establishment.

What is the address of Pharmacie Franco Belge?

The registered office of Pharmacie Franco Belge is located at Anspachlaan 109, 1000 Brussel.

Is Pharmacie Franco Belge still active?

Yes. According to the CBE (15 November 2026) Pharmacie Franco Belge is active, legal situation “Normale toestand”, started on 1 January 1968.

Is Pharmacie Franco Belge registered on Peppol?

Yes, Pharmacie Franco Belge is registered on the Peppol network with ID 0208:0403081916.

What is the enterprise number of Pharmacie Franco Belge?

The enterprise number of Pharmacie Franco Belge is BE0403081916.

When was Pharmacie Franco Belge founded?

Pharmacie Franco Belge was founded on 1 January 1968.

Who are the directors of Pharmacie Franco Belge?

According to the 2025 annual accounts, the directors of Pharmacie Franco Belge are: CHARLES BAPTISTE ALAIN, MICHEL BAPTISTE RENAUD.

Is Pharmacie Franco Belge a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 January 1968; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did Pharmacie Franco Belge make in 2025?

Pharmacie Franco Belge posted a profit after taxes of € 128,888 in financial year 2025.

What is the revenue of Pharmacie Franco Belge?

As a small company, Pharmacie Franco Belge is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 505,481.

How much does an employee at Pharmacie Franco Belge earn?

The average wage cost per full-time employee at Pharmacie Franco Belge was € 49,700 in 2025: staff costs of € 293,281 for 5.9 FTE, according to the annual account at the National Bank. That is the employer's cost, not net pay.

How many employees does Pharmacie Franco Belge have?

According to the 2025 annual accounts, Pharmacie Franco Belge has 5.9 full-time equivalents (FTE).

Pharmacie Franco Belge (Private Limited) - Brussel

Dossier Pharmacie Franco Belge, printed on 15 November 2026 from databakkes.be/en/0403081916/pharmacie-franco-belge. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Pharmacie Franco Belge from Brussel, company number BE0403081916, closed financial year 2025 with a result of € 128,888 after tax. For that financial year Pharmacie Franco Belge recorded a gross margin of € 505,481 and equity of € 481,554. Compared with financial year 2024, the result moved from € 91,718 to € 128,888. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Growing

€ 481,554

▲ 37% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 128,888

▲ 41% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 33,945

▲ 49% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 407,054.

People and assets in 2025

Full-time equivalents

5.9

▼ 0.2 vs 2024

Average over the fiscal year, from the social balance sheet.

Wage cost

€ 293,281

▲ 4% vs 2024

€ 49,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.

Vehicles and equipment

€ 25,969

▲ 175% vs 2024

Of which on lease € 13,592.

Debts at end 2025

Bank debt ≈ 5 years to go

€ 14,412

€ 2,869 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 200,476

▼ 3% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 64,619

▲ 44% vs 2024

Taxes, VAT and social contributions still to pay.

Key figures per fiscal year
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 271,259 Gross margin 2022: € 271,259 First fiscal year in the series	€ 355,319 Gross margin 2023: € 355,319 ▲ 31% vs 2022 (€ 271,259) Favourable step	€ 396,621 Gross margin 2024: € 396,621 ▲ 12% vs 2023 (€ 355,319) Favourable step	€ 505,481 Gross margin 2025: € 505,481 ▲ 27% vs 2024 (€ 396,621) Favourable step	▲ 27%
Profit after taxes	€ -23,559 Profit after taxes 2022: € -23,559 First fiscal year in the series	€ 12,848 Profit after taxes 2023: € 12,848 ▲ € 36,407 vs 2022 (€ -23,559) Favourable step	€ 91,718 Profit after taxes 2024: € 91,718 ▲ € 78,870 vs 2023 (€ 12,848) Favourable step	€ 128,888 Profit after taxes 2025: € 128,888 ▲ 41% vs 2024 (€ 91,718) Favourable step	▲ 41%
Equity	€ 278,101 Equity 2022: € 278,101 First fiscal year in the series	€ 290,949 Equity 2023: € 290,949 ▲ 5% vs 2022 (€ 278,101) Favourable step	€ 352,666 Equity 2024: € 352,666 ▲ 21% vs 2023 (€ 290,949) Favourable step	€ 481,554 Equity 2025: € 481,554 ▲ 37% vs 2024 (€ 352,666) Favourable step	▲ 37%
Total debts	€ 320,760 Total debts 2022: € 320,760 First fiscal year in the series	€ 344,198 Total debts 2023: € 344,198 ▲ 7% vs 2022 (€ 320,760) Unfavourable step	€ 281,304 Total debts 2024: € 281,304 ▼ 18% vs 2023 (€ 344,198) Favourable step	€ 279,967 Total debts 2025: € 279,967 Unchanged (€ 281,304) Favourable step
Cash	€ 23,571 Cash 2022: € 23,571 First fiscal year in the series	€ 33,170 Cash 2023: € 33,170 ▲ 41% vs 2022 (€ 23,571) Favourable step	€ 22,753 Cash 2024: € 22,753 ▼ 31% vs 2023 (€ 33,170) Unfavourable step	€ 33,945 Cash 2025: € 33,945 ▲ 49% vs 2024 (€ 22,753) Favourable step	▲ 49%
Retained profit	€ 203,601 Retained profit 2022: € 203,601 First fiscal year in the series	€ 216,449 Retained profit 2023: € 216,449 ▲ 6% vs 2022 (€ 203,601) Favourable step	€ 278,166 Retained profit 2024: € 278,166 ▲ 29% vs 2023 (€ 216,449) Favourable step	€ 407,054 Retained profit 2025: € 407,054 ▲ 46% vs 2024 (€ 278,166) Favourable step	▲ 46%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 30,000 Dividend 2024: € 30,000 Unchanged (€ 0) Unchanged	€ 0 Dividend 2025: € 0 ▼ 100% vs 2024 (€ 30,000) Unchanged	▼ 100%
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 14,412 Bank debt 2025: € 14,412 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 598,860 Balance sheet total 2022: € 598,860 First fiscal year in the series	€ 635,147 Balance sheet total 2023: € 635,147 ▲ 6% vs 2022 (€ 598,860) Unchanged	€ 633,970 Balance sheet total 2024: € 633,970 Unchanged (€ 635,147) Unchanged	€ 761,521 Balance sheet total 2025: € 761,521 ▲ 20% vs 2024 (€ 633,970) Unchanged	▲ 20%
Employees (FTE)	6.8 Employees (FTE) 2022: 6.8 First fiscal year in the series	6.1 Employees (FTE) 2023: 6.1 ▼ 0.7 vs 2022 (6.8) Unchanged	6.1 Employees (FTE) 2024: 6.1 Unchanged (6.1) Unchanged	5.9 Employees (FTE) 2025: 5.9 ▼ 0.2 vs 2024 (6.1) Unchanged	▼ 0.2

By gross margin, Pharmacie Franco Belge ranks 4th of 24 companies with main activity “Apothekers” in Brussel that publish figures (fiscal year 2025).

Key figures of Pharmacie Franco Belge, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

Ask about Pharmacie Franco Belge the way you would ask their accountant.

Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.

Connect ChatGPT or Claude for free

ChatGPT
Claude

Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.

What happened to Pharmacie Franco Belge?

What happened at Pharmacie Franco Belge in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 128,888 (▲ 41% vs 2024). Source: NBB ↗
2016 MICHEL BAPTISTE RENAUD became a director. NBB
Mar 1, 1980 New establishment in Brussel. KBO
Jan 1, 1968 Start of the company according to the CBE. KBO